Gentamicin dosing in critically ill patients

Acta Anaesthesiologica Scandinavica

Volumn 45, Issue 6, 2001, Pages 734-740

  Hansen, M ^a   Christrup, L L ^a   Jarlov J O ^b   Kampmann, J P ^c   Bonde, J ^a,b  

^a Department of Anaesthesiology   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Institute for Rational Pharmacotherapy   (Denmark)

Author keywords

Critical illness; Dosing interval; Dosing regimen; Gentamicin; Septic patients

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN;

ARTICLE; CLINICAL TRIAL; CRITICAL ILLNESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; NEPHROTOXICITY; OTOTOXICITY; PATIENT MONITORING; PHARMACODYNAMICS; PRIORITY JOURNAL; SEPSIS;

ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; GENTAMICINS; HUMANS;

EID: 0034951189     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2001.045006734.x     Document Type: Article

References (23)

1. Aminoglykosidbehandling II - Dosisregimer på intern-medicinske afdelinger i Danmark
2. Aminoglycosides: Single or multiple daily dosing? A meta-analysis on efficacy and safety
3. Single or multiple daily doses of aminoglycosides: A meta-analysis
4. Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis
5. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once-daily or as divided doses
6. Effectiveness and safety of once-daily aminoglycosides: A meta-analysis
7. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides
8. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides
9. Single daily dosing of aminoglycosides in immunocompromised adults: A systematic review
10. Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration
11. Comparison of gentamicin dosing regimens using an in-vitro model
12. Experience with a once-daily aminoglycoside program administered to 2184 adult patients
13. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: A cost-effectiveness analysis
14. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose
15. Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa
16. Altered aminoglycoside pharmacokinetics in the critically ill
17. Factors affecting gentamicin pharmacokinetics in septic patients
18. Gentamicin volume of distribution in critically ill septic patients
19. Physiologic response of stress and aminoglycoside clearance in critically ill patients
20. Cost-benefit analysis of an aminoglycoside monitoring service
21. Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization
22. Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: A cost-benefit analysis
23. National survey of extended-interval aminoglycoside dosing